| . | Short Duration N = 51 . | Long Duration N = 111 . | P Value . |
|---|---|---|---|
| Age, y, median (IQR) | 59 (47–71) | 59 (49–71) | NS |
| Male sex, n (%) | 29 (56.9) | 52 (46.8) | NS |
| Charlson Comorbidity Index score, median (IQR) | 6 (4–10) | 5 (3–8) | .033 |
| Comorbid conditions, n (%) | |||
| Active chemotherapy within last 90 d | 0 (0) | 0 (0) | NS |
| Autoimmune disorder | 2 (5.7) | 3 (2.4) | NS |
| Bone marrow transplant | 0 (0) | 0 (0) | NS |
| Congestive heart failure | 15 (29.4) | 37 (33.3) | NS |
| Chronic kidney disease | 14 (27.5) | 29 (26.1) | NS |
| COPD | 20 (39.2) | 41 (36.9) | NS |
| Connective tissue disorder | 2 (5.7) | 7 (6.3) | NS |
| CVA | 4 (7.8) | 10 (9) | NS |
| Diabetes | 15 (29.4) | 32 (28.8) | NS |
| Hematologic malignancy | 1 (2) | 5 (4.5) | NS |
| HIV infection | 7 (13.7) | 8 (7.2) | NS |
| Hypogammaglobinemia | 0 (0) | 0 (0) | NS |
| Mild liver diseasea | 17 (33.3) | 21 (18.9) | NS |
| Prior splenectomy | 1 (2) | 1 (0.9) | NS |
| Severe liver diseasea | 7 (13.7) | 9 (8.1) | NS |
| Solid organ transplant | 1 (2) | 1 (0.9) | NS |
| Allergies, n (%) | |||
| Penicillin allergy | 12 (23.5) | 12 (10.8) | NS |
| Non-penicillin antibiotic allergy | 5 (9.8) | 12 (10.8) | NS |
| Severity, n (%) | |||
| Met SIRS criteria | 24 (47.1) | 61 (55) | NS |
| ICU admission/transfer | 12 (23.5) | 34 (30.6) | NS |
| APACHE II score, median (IQR) | 6 (4–7) | 7 (4–13) | NS |
| Pitt bacteremia score ≥1, n (%) | 9 (17.6) | 11 (9.9) | NS |
| . | Short Duration N = 51 . | Long Duration N = 111 . | P Value . |
|---|---|---|---|
| Age, y, median (IQR) | 59 (47–71) | 59 (49–71) | NS |
| Male sex, n (%) | 29 (56.9) | 52 (46.8) | NS |
| Charlson Comorbidity Index score, median (IQR) | 6 (4–10) | 5 (3–8) | .033 |
| Comorbid conditions, n (%) | |||
| Active chemotherapy within last 90 d | 0 (0) | 0 (0) | NS |
| Autoimmune disorder | 2 (5.7) | 3 (2.4) | NS |
| Bone marrow transplant | 0 (0) | 0 (0) | NS |
| Congestive heart failure | 15 (29.4) | 37 (33.3) | NS |
| Chronic kidney disease | 14 (27.5) | 29 (26.1) | NS |
| COPD | 20 (39.2) | 41 (36.9) | NS |
| Connective tissue disorder | 2 (5.7) | 7 (6.3) | NS |
| CVA | 4 (7.8) | 10 (9) | NS |
| Diabetes | 15 (29.4) | 32 (28.8) | NS |
| Hematologic malignancy | 1 (2) | 5 (4.5) | NS |
| HIV infection | 7 (13.7) | 8 (7.2) | NS |
| Hypogammaglobinemia | 0 (0) | 0 (0) | NS |
| Mild liver diseasea | 17 (33.3) | 21 (18.9) | NS |
| Prior splenectomy | 1 (2) | 1 (0.9) | NS |
| Severe liver diseasea | 7 (13.7) | 9 (8.1) | NS |
| Solid organ transplant | 1 (2) | 1 (0.9) | NS |
| Allergies, n (%) | |||
| Penicillin allergy | 12 (23.5) | 12 (10.8) | NS |
| Non-penicillin antibiotic allergy | 5 (9.8) | 12 (10.8) | NS |
| Severity, n (%) | |||
| Met SIRS criteria | 24 (47.1) | 61 (55) | NS |
| ICU admission/transfer | 12 (23.5) | 34 (30.6) | NS |
| APACHE II score, median (IQR) | 6 (4–7) | 7 (4–13) | NS |
| Pitt bacteremia score ≥1, n (%) | 9 (17.6) | 11 (9.9) | NS |
Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation; COPD, chronic obstructive pulmonary disease; CVA, cerebral vascular accident; ICU, intensive care unit; NS, not significant; SIRS, systemic inflammatory response syndrome.
aMild liver disease, chronic hepatitis, or cirrhosis without portal hypertension; severe liver disease, cirrhosis, and portal hypertension with variceal bleeding history or cirrhosis and portal hypertension in the absence of variceal bleeding history.
| . | Short Duration N = 51 . | Long Duration N = 111 . | P Value . |
|---|---|---|---|
| Age, y, median (IQR) | 59 (47–71) | 59 (49–71) | NS |
| Male sex, n (%) | 29 (56.9) | 52 (46.8) | NS |
| Charlson Comorbidity Index score, median (IQR) | 6 (4–10) | 5 (3–8) | .033 |
| Comorbid conditions, n (%) | |||
| Active chemotherapy within last 90 d | 0 (0) | 0 (0) | NS |
| Autoimmune disorder | 2 (5.7) | 3 (2.4) | NS |
| Bone marrow transplant | 0 (0) | 0 (0) | NS |
| Congestive heart failure | 15 (29.4) | 37 (33.3) | NS |
| Chronic kidney disease | 14 (27.5) | 29 (26.1) | NS |
| COPD | 20 (39.2) | 41 (36.9) | NS |
| Connective tissue disorder | 2 (5.7) | 7 (6.3) | NS |
| CVA | 4 (7.8) | 10 (9) | NS |
| Diabetes | 15 (29.4) | 32 (28.8) | NS |
| Hematologic malignancy | 1 (2) | 5 (4.5) | NS |
| HIV infection | 7 (13.7) | 8 (7.2) | NS |
| Hypogammaglobinemia | 0 (0) | 0 (0) | NS |
| Mild liver diseasea | 17 (33.3) | 21 (18.9) | NS |
| Prior splenectomy | 1 (2) | 1 (0.9) | NS |
| Severe liver diseasea | 7 (13.7) | 9 (8.1) | NS |
| Solid organ transplant | 1 (2) | 1 (0.9) | NS |
| Allergies, n (%) | |||
| Penicillin allergy | 12 (23.5) | 12 (10.8) | NS |
| Non-penicillin antibiotic allergy | 5 (9.8) | 12 (10.8) | NS |
| Severity, n (%) | |||
| Met SIRS criteria | 24 (47.1) | 61 (55) | NS |
| ICU admission/transfer | 12 (23.5) | 34 (30.6) | NS |
| APACHE II score, median (IQR) | 6 (4–7) | 7 (4–13) | NS |
| Pitt bacteremia score ≥1, n (%) | 9 (17.6) | 11 (9.9) | NS |
| . | Short Duration N = 51 . | Long Duration N = 111 . | P Value . |
|---|---|---|---|
| Age, y, median (IQR) | 59 (47–71) | 59 (49–71) | NS |
| Male sex, n (%) | 29 (56.9) | 52 (46.8) | NS |
| Charlson Comorbidity Index score, median (IQR) | 6 (4–10) | 5 (3–8) | .033 |
| Comorbid conditions, n (%) | |||
| Active chemotherapy within last 90 d | 0 (0) | 0 (0) | NS |
| Autoimmune disorder | 2 (5.7) | 3 (2.4) | NS |
| Bone marrow transplant | 0 (0) | 0 (0) | NS |
| Congestive heart failure | 15 (29.4) | 37 (33.3) | NS |
| Chronic kidney disease | 14 (27.5) | 29 (26.1) | NS |
| COPD | 20 (39.2) | 41 (36.9) | NS |
| Connective tissue disorder | 2 (5.7) | 7 (6.3) | NS |
| CVA | 4 (7.8) | 10 (9) | NS |
| Diabetes | 15 (29.4) | 32 (28.8) | NS |
| Hematologic malignancy | 1 (2) | 5 (4.5) | NS |
| HIV infection | 7 (13.7) | 8 (7.2) | NS |
| Hypogammaglobinemia | 0 (0) | 0 (0) | NS |
| Mild liver diseasea | 17 (33.3) | 21 (18.9) | NS |
| Prior splenectomy | 1 (2) | 1 (0.9) | NS |
| Severe liver diseasea | 7 (13.7) | 9 (8.1) | NS |
| Solid organ transplant | 1 (2) | 1 (0.9) | NS |
| Allergies, n (%) | |||
| Penicillin allergy | 12 (23.5) | 12 (10.8) | NS |
| Non-penicillin antibiotic allergy | 5 (9.8) | 12 (10.8) | NS |
| Severity, n (%) | |||
| Met SIRS criteria | 24 (47.1) | 61 (55) | NS |
| ICU admission/transfer | 12 (23.5) | 34 (30.6) | NS |
| APACHE II score, median (IQR) | 6 (4–7) | 7 (4–13) | NS |
| Pitt bacteremia score ≥1, n (%) | 9 (17.6) | 11 (9.9) | NS |
Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation; COPD, chronic obstructive pulmonary disease; CVA, cerebral vascular accident; ICU, intensive care unit; NS, not significant; SIRS, systemic inflammatory response syndrome.
aMild liver disease, chronic hepatitis, or cirrhosis without portal hypertension; severe liver disease, cirrhosis, and portal hypertension with variceal bleeding history or cirrhosis and portal hypertension in the absence of variceal bleeding history.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
